{"slideshow_credits": null, "snippet": "The American drug company\u2019s retreat, writes Neil Unmack of Reuters Breakingviews, will make it difficult for the board of any European company to approve an inversion bid in the future.", "abstract": "The American drug company\u2019s retreat, writes Neil Unmack of Reuters Breakingviews, will make it difficult for the board of any European company to approve an inversion bid in the future.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Neil", "role": "reported", "lastname": "UNMACK", "rank": 1, "organization": ""}], "original": "By NEIL UNMACK"}, "web_url": "http://dealbook.nytimes.com/2014/10/15/abbvies-u-turn-shows-shire-deal-was-driven-by-taxes/", "lead_paragraph": null, "headline": {"main": "AbbVie's U-Turn Shows Shire Deal Was Driven by Taxes", "kicker": "DealBook"}, "_id": "543ea2e438f0d853e89f6529", "word_count": "385", "multimedia": [{"height": 126, "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 360, "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-articleLarge.jpg", "legacy": {"xlarge": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "360"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-10-15T11:59:18Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "AbbVie Inc", "name": "organizations", "rank": "1"}, {"value": "AstraZeneca PLC", "name": "organizations", "rank": "2"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "3"}, {"value": "Shire PLC", "name": "organizations", "rank": "4"}, {"value": "Treasury Department", "name": "organizations", "rank": "5"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}